Ekso Bionics Holdings, Inc. (EKSO)

Ekso Bionics Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	35	13	36	16	34	51
Market Cap Growth	146.91%	-62.29%	127.55%	-53.40%	-34.17%	51.49%
Enterprise Value	37	11	33	-10	-8	40
Last Close Price	9.84	9.15	37.50	17.85	39.75	91.95
PS Ratio	1.36	0.75	1.95	1.21	2.98	5.74
PB Ratio	2.67	1.06	2.82	0.62	0.90	11.50
P/TBV Ratio	6.88	1.74	4.89	0.79	0.90	11.50
EV/Sales Ratio	2.53	0.64	1.81	-	-	4.54
Debt / Equity Ratio	0.51	0.47	0.57	0.30	0.06	0.87
Asset Turnover	0.58	0.65	0.52	0.29	0.32	0.42
Inventory Turnover	1.37	1.75	1.80	1.80	2.13	1.71
Quick Ratio	0.98	1.82	1.76	2.73	6.57	3.23
Current Ratio	1.66	2.50	2.49	3.37	6.97	3.70
Return on Equity (ROE)	-85.00%	-89.52%	-79.89%	-48.13%	-46.88%	-281.81%
Return on Assets (ROA)	-27.15%	-23.53%	-27.05%	-21.59%	-24.78%	-37.81%
Return on Capital Employed (ROCE)	-86.80%	-54.70%	-72.70%	-49.10%	-32.70%	-82.30%
Earnings Yield	-30.40%	-84.43%	-42.71%	-96.42%	-29.09%	-31.04%
FCF Yield	-25.63%	-73.65%	-34.31%	-95.16%	-33.42%	-17.17%
Buyback Yield / Dilution	-73.41%	-45.39%	-6.98%	-5.65%	-71.26%	-49.44%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q